Page 1 | Search Results | Hematology, ASH Education Program

1-20 of 24

Sort by

Sort Order Select

Journal Articles

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Simon Rule

Hematology Am Soc Hematol Educ Program (2016) 2016 (1): 419–424.

https://doi.org/10.1182/asheducation-2016.1.419

Published: 2016

Journal Articles

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Clive S. Zent, W. Richard Burack

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 119–124.

https://doi.org/10.1182/asheducation-2014.1.119

Published: 2014

Journal Articles

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

Sarah Nikiforow, Edwin P. Alyea

Hematology Am Soc Hematol Educ Program (2014) 2014 (1): 570–575.

https://doi.org/10.1182/asheducation-2014.1.570

Published: 2014

Journal Articles

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence

Koen van Besien

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 56–62.

https://doi.org/10.1182/asheducation-2013.1.56

Published: 2013

Journal Articles

Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease

Eliane Gluckman

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 370–376.

https://doi.org/10.1182/asheducation-2013.1.370

Published: 2013

Journal Articles

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

Uwe Platzbecker

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 522–528.

https://doi.org/10.1182/asheducation-2013.1.522

Published: 2013

Journal Articles

Transplantation in HIV-infected subjects: is cure possible?

John A. Zaia, Stephen J. Forman

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 389–393.

https://doi.org/10.1182/asheducation-2013.1.389

Published: 2013

Journal Articles

High-risk acute myelogenous leukemia: treatment today … and tomorrow

Gary J. Schiller

Hematology Am Soc Hematol Educ Program (2013) 2013 (1): 201–208.

https://doi.org/10.1182/asheducation-2013.1.201

Published: 2013

Journal Articles

Treatment of acute myeloid leukemia: are we making progress?

Alan K. Burnett

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 1–6.

https://doi.org/10.1182/asheducation.V2012.1.1.3797038

Published: 2012

Journal Articles

Do different conditioning regimens really make a difference?

Didier Blaise, Luca Castagna

Hematology Am Soc Hematol Educ Program (2012) 2012 (1): 237–245.

https://doi.org/10.1182/asheducation.V2012.1.237.3798315

Published: 2012

Journal Articles

Novel Insights into the Biology of CLL

Mark C. Lanasa

Hematology Am Soc Hematol Educ Program (2010) 2010 (1): 70–76.

https://doi.org/10.1182/asheducation-2010.1.70

Published: 2010

Journal Articles

Transplantation in adult ALL

Anthony H. Goldstone, Jacob M. Rowe

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 593–601.

https://doi.org/10.1182/asheducation-2009.1.593

Published: 2009

Journal Articles

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

Stephen J. Forman

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 406–413.

https://doi.org/10.1182/asheducation-2009.1.406

Published: 2009

Journal Articles

Allotransplantation for chronic lymphocytic leukemia

Peter Dreger

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 602–609.

https://doi.org/10.1182/asheducation-2009.1.602

Published: 2009

Journal Articles

How to treat a newly diagnosed young patient with multiple myeloma

Jesús F. San-Miguel, María-Victoria Mateos

Hematology Am Soc Hematol Educ Program (2009) 2009 (1): 555–565.

https://doi.org/10.1182/asheducation-2009.1.555

Published: 2009

Journal Articles

From Palliation to Epigenetic Therapy in Myelofibrosis

Alessandro Rambaldi, Tiziano Barbui, Giovanni Barosi

Hematology Am Soc Hematol Educ Program (2008) 2008 (1): 83–91.

https://doi.org/10.1182/asheducation-2008.1.83

Published: 2008

Journal Articles

Reduced-Intensity Stem Cell Transplantation: “...whereof a little More than a little is by much too much.” King Henry IV, part 1, I, 2

Joseph H. Antin

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 47–54.

https://doi.org/10.1182/asheducation-2007.1.47

Published: 2007

Journal Articles

Towards the Generation of Patient-Specific Pluripotent Stem Cells for Combined Gene and Cell Therapy of Hematologic Disorders

George Q. Daley

Hematology Am Soc Hematol Educ Program (2007) 2007 (1): 17–22.

https://doi.org/10.1182/asheducation-2007.1.17

Published: 2007

Journal Articles

Vaccine-Enhanced Donor Lymphocyte Infusion (veDLI)

John D. Roback

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 486–491.

https://doi.org/10.1182/asheducation-2006.1.486

Published: 2006

Journal Articles

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

Issa F. Khouri

Hematology Am Soc Hematol Educ Program (2006) 2006 (1): 390–397.

https://doi.org/10.1182/asheducation-2006.1.390

Published: 2006

Update search

NARROW

Publications

Format

Article Type

Topics

Date

Availability

Frontline therapy and role of high-dose consolidation in mantle cell lymphoma

Mutations in chronic lymphocytic leukemia and how they affect therapy choice: focus on NOTCH1 , SF3B1 , and TP53

Maximizing GVL in allogeneic transplantation: role of donor lymphocyte infusions

Allogeneic transplantation for AML and MDS: GVL versus GVHD and disease recurrence

Allogeneic transplantation strategies including haploidentical transplantation in sickle cell disease

Who benefits from allogeneic transplantation for myelodysplastic syndromes?: new insights

Transplantation in HIV-infected subjects: is cure possible?

High-risk acute myelogenous leukemia: treatment today … and tomorrow

Treatment of acute myeloid leukemia: are we making progress?

Do different conditioning regimens really make a difference?

Novel Insights into the Biology of CLL

Transplantation in adult ALL

What is the role of reduced-intensity transplantation in the treatment of older patients with AML?

Allotransplantation for chronic lymphocytic leukemia

How to treat a newly diagnosed young patient with multiple myeloma

From Palliation to Epigenetic Therapy in Myelofibrosis

Reduced-Intensity Stem Cell Transplantation: “...whereof a little More than a little is by much too much.” King Henry IV, part 1, I, 2

Towards the Generation of Patient-Specific Pluripotent Stem Cells for Combined Gene and Cell Therapy of Hematologic Disorders

Vaccine-Enhanced Donor Lymphocyte Infusion (veDLI)

Reduced-Intensity Regimens in Allogeneic Stem-Cell Transplantation for Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia

ASH Publications

American Society of Hematology